EP. 1: Need for Awareness About BiosimilarsByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 2: Overview of BiosimilarsByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 3: Biosimilar Approval Process by Regulatory BodiesByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 4: Review of the Phase III Clinical Trial for Biosimilar SB11ByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 5: Key Clinical Findings on the Efficacy, Safety Profile and Immunogenicity of Biosimilar SB11ByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 6: Impact of Biosimilars on the Healthcare SystemByThis program is initiated, funded, and developed by Biogen.April 18th 2024
EP. 7: Selecting the Right Patients for Anti-VEGF Biosimilar TherapyByThis program is initiated, funded, and developed by Biogen.April 18th 2024
